Differentiation of autoimmune pancreatitis from suspected pancreatic cancer by fluorine-18 fluorodeoxyglucose positron emission tomography

Journal of Gastroenterology

Volumn 43, Issue 2, 2008, Pages 144-151

  Ozaki, Y Yayoi ^a   Oguchi, Kazuhiro ^b   Hamano, Hideaki ^a   Arakura, Norikazu ^a   Muraki, Takashi ^a   Kiyosawa, Kendo ^a   Momose, Mitsuhiro ^a   Kadoya, Masumi ^a   Miyata, Kazunobu ^b   Aizawa, Takao ^b   Kawa, Shigeyuki ^c  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Aizawa Hospital   (Japan)

^c SHINSHU UNIVERSITY   (Japan)

Author keywords

Autoimmune pancreatitis; FDG PET; Pancreatic cancer

Indexed keywords

FLUORODEOXYGLUCOSE F 18; IMMUNOGLOBULIN G4;

ADULT; AGED; ARTICLE; AUTOIMMUNE PANCREATITIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DRUG UPTAKE; FEMALE; HUMAN; IMAGE ANALYSIS; IMMUNOGLOBULIN BLOOD LEVEL; LACRIMAL GLAND; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; PANCREAS CANCER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSTATE; QUANTITATIVE ANALYSIS; RETROPERITONEUM; SALIVARY GLAND;

ADENOCARCINOMA; ADULT; AGED; AUTOIMMUNE DISEASES; DIAGNOSIS, DIFFERENTIAL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PANCREATITIS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS;

EID: 40449129067     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-007-2132-y     Document Type: Article

References (34)

1. Delbeke D, Rose DM, Chapman WC, Pinson CW, Wright JK, Beauchamp RD, et al. Optimal interpretation of FDG PET in the diagnosis, staging and management of pancreatic carcinoma. J Nucl Med 1999;40:1784-1791.
2. Imdahl A, Nitzsche E, Krautmann F, Hogerle S, Boos S, Einert A, et al. Evaluation of positron emission tomography with 2-[18F]fluoro-2-deoxy- D -glucose for the differentiation of chronic pancreatitis and pancreatic cancer. Br J Surg 1999;86:194-199.
3. Inokuma T, Tamaki N, Torizuka T, Magata Y, Fujii M, Yonekura Y, et al. Evaluation of pancreatic tumors with positron emission tomography and F-18 fluorodeoxyglucose: Comparison with CT and US. Radiology 1995;195:345-352.
4. Zimny M, Bares R, Fass J, Adam G, Cremerius U, Dohmen B, et al. Fluorine-18 fluorodeoxyglucose positron emission tomography in the differential diagnosis of pancreatic carcinoma: A report of 106 cases. Eur J Nucl Med 1997;24:678-682.
5. Nakamoto Y, Higashi T, Sakahara H, Tamaki N, Kogire M, Doi R, et al. Delayed (18)F-fluoro-2-deoxy- d -glucose positron emission tomography scan for differentiation between malignant and benign lesions in the pancreas. Cancer 2000;89:2547-2554.
6. van Kouwen MC, Jansen JB, van Goor H, de Castro S, Oyen WJ, Drenth JP. FDG-PET is able to detect pancreatic carcinoma in chronic pancreatitis. Eur J Nucl Med Mol Imaging 2005;32:399-404.
7. Heinrich S, Goerres GW, Schafer M, Sagmeister M, Bauerfeind P, Pestalozzi BC, et al. Positron emission tomography/computed tomography influences on the management of resectable pancreatic cancer and its cost-effectiveness. Ann Surg 2005;242:235-243.
8. Toki F, Kozu T, Oi I, Nakasato T, Suzuki M, Hanyu F. An unusual type of chronic pancreatitis showing diffuse irregular narrowing of the entire main pancreatic duct on ERCP-a report of four cases. Endoscopy 1992;24:640.
9. Yoshida K, Toki F, Takeuchi T, Watanabe S, Shiratori K, Hayashi N. Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci 1995;40:1561-1568.
10. Ito T, Nakano I, Koyanagi S, Miyahara T, Migita Y, Ogoshi K, et al. Autoimmune pancreatitis as a new clinical entity. Three cases of autoimmune pancreatitis with effective steroid therapy. Dig Dis Sci 1997;42:1458-1468.
11. Horiuchi A, Kawa S, Akamatsu T, Aoki Y, Mukawa K, Furuya N, et al. Characteristic pancreatic duct appearance in autoimmune chronic pancreatitis: A case report and review of the Japanese literature. Am J Gastroenterol 1998;93:260-263.
12. Horiuchi A, Kawa S, Hamano H, Hayama M, Ota H, Kiyosawa K. ERCP features in 27 patients with autoimmune pancreatitis. Gastrointest Endosc 2002;55:494-499.
13. Abraham SC, Wilentz RE, Yeo CJ, Yeo CJ, Sohn TA, Cameron JL, Boitnott, et al. Pancreaticoduodenectomy (Whipple resection) in patients without malignancy. Am J Surg Pathol 2003;27:110-120.
14. Kawa S, Hamano H, Kiyosawa K. Pancreatitis. In: Rose NR, MacKay IR, editors. The autoimmune diseases. 4th ed. St Louis: Academic; 2006. p. 779-786.
15. Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, Akamatsu T, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 2001;344:732-738.
16. Hamano H, Kawa S, Ochi Y, Unno H, Shiba N, Wajiki M, et al. Hydronephrosis associated with retroperitoneal fibrosis and sclerosing pancreatitis. Lancet 2002;359:1403-1404.
17. Strauss LG. Fluorine-18 deoxyglucose and false-positive results: A major problem in the diagnostics of oncological patients. Eur J Nucl Med 1996;23:1409-1415.
18. Shreve PD. Focal fluorine-18 fluorodeoxyglucose accumulation in inflammatory pancreatic disease. Eur J Nucl Med 1998;25:259-264.
19. Higashi T, Saga T, Nakamoto Y, Ishimori T, Fujimoto K, Doi R, et al. Diagnosis of pancreatic cancer using fluorine-18 fluorodeoxyglucose positron emission tomography (FDG PET)-usefulness and limitations in "clinical reality". Ann Nucl Med 2003;17:261-279.
20. Yokoyama Y, Nagino M, Hiromatsu T, Yuasa N, Oda K, Arai T, et al. Intense PET signal in the degenerative necrosis superimposed on chronic pancreatitis. Pancreas 2005;31:192-194.
21. Huang B, Puri S. Pancreatic pseudocyst observed on F-18 FDG PET imaging. Clin Nucl Med 2005;30:259-261.
22. Sperti C, Pasquali C, Decet G, Chierichetti F, Liessi G, Pedrazzoli S. F-18-fluorodeoxyglucose positron emission tomography in differentiating malignant from benign pancreatic cysts: A prospective study. J Gastrointest Surg 2005;9:22-28; discussion 28-9.
23. Nakamoto Y, Sakahara H, Higashi T, Saga T, Sato N, Okazaki K, et al. Autoimmune pancreatitis with F-18 fluoro-2-deoxy- d -glucose PET findings Clin Nucl Med. 1999;24:778-780.
24. Nakamoto Y, Saga T, Ishimori T, Higashi T, Mamede M, Okazaki K, et al. FDG-PET of autoimmune-related pancreatitis: Preliminary results. Eur J Nucl Med 2000;27:1835-1838.
25. Members of the Criteria Committee for Autoimmune Pancreatitis of the Japan Pancreas Society. Diagnostic criteria for autoimmune pancreatitis by the Japan Pancreas Society. J Jpn Pancreas (Suizou) 2002;17:587.
26. Okazaki K, Kawa S, Kamisawa T, Naruse S, Tanaka S, Nishimori I, et al. Clinical diagnostic criteria of autoimmune pancreatitis: Revised proposal. J Gastroenterol 2006;41:626-631.
27. Bares R, Klever P, Hauptmann S, Hellwig D, Fass J, Cremerius U, et al. F-18 fluorodeoxyglucose PET in vivo evaluation of pancreatic glucose metabolism for detection of pancreatic cancer. Radiology 1994;192:79-86.
28. Diederichs CG, Staib L, Glasbrenner B, Guhlmann A, Glatting G, Pauls S, et al. F-18 fluorodeoxyglucose (FDG) and C-reactive protein (CRP). Clin Positron Imaging 1999;2:131-136.
29. Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 1992;33:1972-1980.
30. Sperti C, Pasquali C, Decet G, Chierichetti F, Liessi G, Pedrazzoli S. F-18-fluorodeoxyglucose positron emission tomography in differentiating malignant from benign pancreatic cysts: A prospective study. J Gastrointest Surg 2005;9:22-28.
31. Heinrich S, Goerres GW, Schafer M, Sagmeister M, Bauerfeind P, Pestalozzi BC, et al. Positron emission tomography/computed tomography influences on the management of resectable pancreatic cancer and its cost-effectiveness. Ann Surg 2005;242:235-243.
32. Hamano H, Arakura N, Muraki T, Ozaki Y, Kiyosawa K, Kawa S. Prevalence and distribution of extra-pancreatic lesions complicated with autoimmune pancreatitis. J Gastroenterol 2006;41:1197-1205.
33. Saegusa H, Momose M, Kawa S, Hamano H, Ochi Y, Takayama M, et al. Hilar and pancreatic gallium-67 accumulation is characteristic feature of autoimmune pancreatitis. Pancreas 2003;27:20-25.
34. Hustinx R, Lemaire C, Jerusalem G, Moreau P, Cataldo D, Duysinx B, et al. Whole-body tumor imaging using PET and 2-18F-fluoro- l -tyrosine: preliminary evaluation and comparison with 18F-FDG. J Nucl Med 2003;44:533-539.